Publication:
Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement.

dc.contributor.authorOtero-Romero, S
dc.contributor.authorRodríguez-García, J
dc.contributor.authorVilella, A
dc.contributor.authorAra, J R
dc.contributor.authorBrieva, L
dc.contributor.authorCalles, C
dc.contributor.authorCarmona, O
dc.contributor.authorCasanova, V
dc.contributor.authorCosta-Frossard, L
dc.contributor.authorEichau, S
dc.contributor.authorGarcía-Merino, J A
dc.contributor.authorGarcia-Vidal, C
dc.contributor.authorGonzález-Platas, M
dc.contributor.authorLlaneza, M
dc.contributor.authorMartínez-Ginés, M
dc.contributor.authorMeca-Lallana, J E
dc.contributor.authorPrieto, J M
dc.contributor.authorRodríguez-Antigüedad, A
dc.contributor.authorTintoré, M
dc.contributor.authorBlanco, Y
dc.contributor.authorMoral, E
dc.contributor.authoren nombre del Grupo de enfermedades desmielizantes de la SEN
dc.date.accessioned2023-02-09T09:35:50Z
dc.date.available2023-02-09T09:35:50Z
dc.date.issued2020-06-17
dc.description.abstractThe recent development of highly effective treatments for multiple sclerosis (MS) and the potential risk of infectious complications require the development of prevention and risk minimisation strategies. Vaccination is an essential element of the management of these patients. This consensus statement includes a series of recommendations and practical scenarios for the vaccination of adult patients with MS who are eligible for highly effective immunosuppressive treatments. A formal consensus procedure was followed. Having defined the scope of the statement, we conducted a literature search on recommendations for the vaccination of patients with MS and specific vaccination guidelines for immunosuppressed patients receiving biological therapy for other conditions. The modified nominal group technique methodology was used to formulate the recommendations. Vaccination in patients who are candidates for immunosuppressive therapy should be considered before starting immunosuppressive treatment providing the patient's clinical situation allows. Vaccines included in the routine adult vaccination schedule, as well as some specific ones, are recommended depending on the pre-existing immunity status. If immunosuppressive treatment is already established, live attenuated vaccines are contraindicated. For vaccines with a correlate of protection, it is recommended to monitor the serological response in an optimal interval of 1-2 months from the last dose.
dc.identifier.doi10.1016/j.nrl.2020.02.006
dc.identifier.essn2173-5808
dc.identifier.pmid32561334
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.nrl.2020.02.006
dc.identifier.urihttp://hdl.handle.net/10668/15779
dc.issue.number1
dc.journal.titleNeurologia (Barcelona, Spain)
dc.journal.titleabbreviationNeurologia (Engl Ed)
dc.language.isoen
dc.language.isoes
dc.organizationHospital Universitario Virgen del Rocío
dc.organizationHospital Universitario Virgen Macarena
dc.page.number50-60
dc.pubmedtypeJournal Article
dc.pubmedtypePractice Guideline
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectConsenso
dc.subjectConsensus
dc.subjectEsclerosis múltiple
dc.subjectImmunosuppression
dc.subjectInmunosupresión
dc.subjectMultiple sclerosis
dc.subjectRecomendaciones
dc.subjectRecommendations
dc.subjectVaccination
dc.subjectVacunación
dc.subject.meshAdult
dc.subject.meshConsensus
dc.subject.meshHumans
dc.subject.meshImmunosuppression Therapy
dc.subject.meshMultiple Sclerosis
dc.subject.meshVaccination
dc.subject.meshVaccines, Attenuated
dc.titleRecommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement.
dc.title.alternativeRecomendaciones para la vacunación en pacientes con esclerosis múltiple candidatos a terapias inmunosupresoras: documento de consenso español.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number36
dspace.entity.typePublication

Files